Search Results 1631-1640 of 3936 for Solid

  1. Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer - Mayo Clinic

    ... solid tumours including lymphomas (without bone marrow involvement) curatively treated with no evidence of disease for ≥ 5 years prior to randomization.

  2. Placebo Controlled Study of VS-6063 in Subjects with Malignant Pleural Mesothelioma - Mayo Clinic

    Progression will be assessed both locally and by central review using the Response Evaluation Criteria In Solid Tumors (RECIST) Version 1.1. Subjects will ...

  3. A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma - Mayo Clinic

    Presence of measurable or nonmeasurable but evaluable disease as defined by the Response Evaluation Criteria in Solid Tumors (RECIST 1.1, Eisenhauer et al.

  4. First in Human Study of TORL-4-500 in Participants With Advanced Cancer - Mayo Clinic

    Contact the study team to discuss study eligibility and potential participation. Show more eligibility criteria. Inclusion Criteria: * Advanced solid tumor * ...

  5. Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery - Mayo Clinic

    Nodules 1-4 cm with solid appearance on ultrasound; Ultrasound images and report documented in medical record, including the size of the nodule and location ...

  6. Prevention Of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Oncology (Medical) - Clinical trials

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors.

  8. Chicken salad with Thai flavors - Mayo Clinic

    Strain the cooled stock and discard the solids. Return 1 1/2 cups of the stock to the saucepan; discard the remaining liquid. Bring to a boil over medium ...

  9. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation - Mayo Clinic

    History of solid organ transplantation. 20. Signs and symptoms of active central nervous system disease. 21. Life expectancy <6 months as assessed by the ...

  10. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

    Measurable disease by Response Evaluation Criteria In Solid Tumors (RECIST) criteria; (evaluable disease is allowed only for the Safety Lead-In phase); Prior ...